Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Active, Not Recruiting

Nudge to Gynecologic Oncology

NCT06451263

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

NCT05617755

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adnexal Diseases, +29 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • U of Colorado Cancer Center - Anschutz Medical Campus Aurora, Colorado, United States
  • U of Iowa Health Care Iowa City, Iowa, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

NCT03522246

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +30 more
Locations
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Clinical Research Center Concord, California, United States
View all 238 locations
View Trial Details
Active, Not Recruiting

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

NCT02571725

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Southwest Gynecologic Oncology Associates Albuquerque, New Mexico, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

NCT05257408

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
Locations
  • Site 318 Phoenix, Arizona, United States
  • Site 277 Tucson, Arizona, United States
  • Site 350 Irvine, California, United States
  • Site 364 La Jolla, California, United States
View all 117 locations
View Trial Details

Related conditions